TP53 and neoplasm: As p53, p21 and p27 phospho-kinase proteins play essential roles in tumour progression and clinical outcomes in acute lymphoblastic leukaemia, the presence and activity regulatory proteins should be taken into consideration in devising personalized treatment regimens.